Exhibit 31.1
Certification Pursuant toSection 240.13a-14 or240.15d-14
of the Securities Exchange Act of 1934, as amended
I, Jay R. Luly, certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form10-K of Enanta Pharmaceuticals, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: January 6, 2017
/s/ Jay R. Luly, Ph.D. |
Jay R. Luly, Ph.D. Chief Executive Officer |